Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1981 1
1993 1
1995 1
1997 1
1998 2
2001 1
2004 2
2005 1
2010 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression.
Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y. Kramer MS, et al. Among authors: getson a. Neuropsychopharmacology. 2004 Feb;29(2):385-92. doi: 10.1038/sj.npp.1300260. Neuropsychopharmacology. 2004. PMID: 14666114 Clinical Trial.
Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.
Shedden A, Adamsons IA, Getson AJ, Laurence JK, Lines CR, Hewitt DJ, Ho TW. Shedden A, et al. Among authors: getson aj. Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1757-64. doi: 10.1007/s00417-010-1397-7. Epub 2010 May 2. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20437244 Clinical Trial.
Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.
Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups. Fechtner RD, et al. Among authors: getson aj. Acta Ophthalmol Scand. 2004 Feb;82(1):42-8. doi: 10.1046/j.1600-0420.2004.0205.x. Acta Ophthalmol Scand. 2004. PMID: 14982045 Free article. Clinical Trial.
13 results